In a prospective study of 71 patients with Fontaine stage II-IV PAD, Tschopl et al. [19] studied the role and values of various known hemostatic factors that may be associated with an increased risk of thrombosis and identified that patients with restenosis of atherosclerotic lesions had higher CRP values at 3–6 months after PTA (25.4 +/− 46.7 versus 7.9 +/− 6.9 mg/L, p < 0.05). Here, CRP is linked to peripheral arterial disease.